首页> 中文期刊> 《中国病毒学:英文版》 >KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China

KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China

         

摘要

Dear Editor,Natural killer(NK)cells are lymphocytes that play important roles in the host defense against hepatitis C virus(HCV)infection.Killer cell immunoglobulin-like receptors(KIRs)are a group of regulatory molecules expressed on NK cells and a subset of T cells(Parham 2005).Ligands for KIRs are human leukocyte antigen(HLA)class Ⅰ molecules,and HLA-C1 is a ligand for the inhibitory

著录项

  • 来源
    《中国病毒学:英文版》 |2018年第4期|P.369-372|共4页
  • 作者单位

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

    Medical College, Jianghan University;

    Department of Immunology, School of Basic Medicine,Tongji Medical College, Huazhong University of Science and Technology;

    Department of Pathogen Biology, Tongji Medical College,Huazhong University of Science and Technology;

  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 R512.63;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号